A New Rapid-Response Strategy for Suicidal Depression? Stanford Researchers Explore Ketamine Followed by Buprenorphine | Reno, Nevada |

ketamine has rapidly emerged as one of the most effective treatments for treatment-resistant depression (TRD).

But with its growing use, a critical question comes up:

👉 Does ketamine cause tachyphylaxis (loss of effect) or dependence over time?

For patients in Reno, Nevada, considering this therapy, it’s essential to separate evidence from assumption—especially given ketamine’s history outside of medical settings.